Regeneron Pharmaceuticals (REGN) Receivables (2009 - 2026)
Regeneron Pharmaceuticals' quarterly Receivables came in at $5.7 billion in Q1 2026, up 3.06% year-on-year from $5.6 billion in Q1 2025, and little changed quarter-over-quarter from $5.7 billion in Q4 2025.
Regeneron Pharmaceuticals has reported Receivables for 18 years, with the latest figure at $5.7 billion in Q1 2026.
- For the quarter ending Q1 2026, Receivables rose 3.06% year-over-year to $5.7 billion; the trailing twelve-month figure through Mar 2026 stood at $5.7 billion (up 3.06% YoY), and the FY2025 full-year result was $5.7 billion, down 7.58% from the prior year.
- Receivables for Q1 2026 stood at $5.7 billion, roughly flat from $5.7 billion in the prior quarter.
- The five-year high for Receivables was $6.2 billion in Q4 2024, with the low at $4.8 billion in Q1 2022.
- Average Receivables over 5 years is $5.5 billion, with a median of $5.6 billion recorded in 2023.
- Peak annual rise in Receivables reached 15.96% in 2022, while the deepest fall reached 26.25% in 2022.
- Tracing REGN's Receivables over 5 years: stood at $5.3 billion in 2022, then climbed by 6.35% to $5.7 billion in 2023, then rose by 9.61% to $6.2 billion in 2024, then slipped by 7.58% to $5.7 billion in 2025, then slipped by 0.18% to $5.7 billion in 2026.
- The last three Receivables figures came in at $5.7 billion (Q1 2026), $5.7 billion (Q4 2025), and $5.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 13.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 4.15 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.00 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.73 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 883.96 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.73 Bn |
| Dec 31, 2025 | 5.74 Bn |
| Sep 30, 2025 | 5.69 Bn |
| Jun 30, 2025 | 5.61 Bn |
| Mar 31, 2025 | 5.56 Bn |
| Dec 31, 2024 | 6.21 Bn |
| Sep 30, 2024 | 6.11 Bn |
| Jun 30, 2024 | 5.72 Bn |
| Mar 31, 2024 | 5.22 Bn |
| Dec 31, 2023 | 5.67 Bn |
| Sep 30, 2023 | 5.58 Bn |
| Jun 30, 2023 | 5.12 Bn |
| Mar 31, 2023 | 5.12 Bn |
| Dec 31, 2022 | 5.33 Bn |
| Sep 30, 2022 | 5.55 Bn |
| Jun 30, 2022 | 5.16 Bn |
| Mar 31, 2022 | 4.84 Bn |
| Dec 31, 2021 | 6.04 Bn |
| Sep 30, 2021 | 5.45 Bn |
| Jun 30, 2021 | 7.00 Bn |
| Mar 31, 2021 | 4.17 Bn |
| Dec 31, 2020 | 4.11 Bn |
| Sep 30, 2020 | 3.55 Bn |
| Jun 30, 2020 | 820.30 Mn |
| Mar 31, 2020 | 870.10 Mn |
| Dec 31, 2019 | 685.60 Mn |
| Sep 30, 2019 | 632.30 Mn |
| Jun 30, 2019 | 535.70 Mn |
| Mar 31, 2019 | 576.80 Mn |
| Dec 31, 2018 | 519.50 Mn |
| Sep 30, 2018 | 537.21 Mn |
| Jun 30, 2018 | 504.92 Mn |
| Mar 31, 2018 | 412.00 Mn |
| Dec 31, 2017 | 435.70 Mn |
| Sep 30, 2017 | 438.76 Mn |
| Jun 30, 2017 | 424.14 Mn |
| Mar 31, 2017 | 409.75 Mn |
| Dec 31, 2016 | 268.25 Mn |
| Sep 30, 2016 | 311.80 Mn |
| Jun 30, 2016 | 320.01 Mn |
| Mar 31, 2016 | 414.65 Mn |
| Dec 31, 2015 | 315.30 Mn |
| Sep 30, 2015 | 1.29 Bn |
| Jun 30, 2015 | 1.27 Bn |
| Mar 31, 2015 | 1.18 Bn |
| Dec 31, 2014 | 850.89 Mn |
| Sep 30, 2014 | 784.64 Mn |
| Jun 30, 2014 | 229.85 Mn |
| Mar 31, 2014 | 919.78 Mn |
| Dec 31, 2013 | 167.90 Mn |
| Sep 30, 2013 | 992.82 Mn |
| Jun 30, 2013 | 876.02 Mn |
| Mar 31, 2013 | 802.64 Mn |
| Dec 31, 2012 | 693.12 Mn |
| Sep 30, 2012 | 601.27 Mn |
| Jun 30, 2012 | 435.38 Mn |
| Mar 31, 2012 | 238.35 Mn |
| Dec 31, 2011 | 103.04 Mn |
| Sep 30, 2011 | 78.45 Mn |
| Jun 30, 2011 | 84.56 Mn |
| Mar 31, 2011 | 88.16 Mn |
| Dec 31, 2010 | 81.92 Mn |
| Sep 30, 2010 | 82.29 Mn |
| Jun 30, 2010 | 95.20 Mn |
| Dec 31, 2009 | 65.57 Mn |